Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 623 publications
Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.
Journal: JAMA surgery
Published: September 17, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Journal: Journal of the American College of Cardiology
Published: July 23, 2025
Multi-database pharmacovigilance assessment of GLP-1 receptor agonist-related ophthalmic risks using advanced signal detection in FAERS and vigibase.
Journal: Journal of endocrinological investigation
Published: July 08, 2025
Efficacy and safety of iGlarLixi versus IDegAsp by baseline β-cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli-D study.
Journal: Diabetes, obesity & metabolism
Published: July 02, 2025
From diabetes to dopamine: Evaluating the disease-modifying potential of GLP-1 receptor agonists in Parkinson's disease. A systematic review and meta-analysis of placebo-controlled trials.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 23, 2025
Antidiabetic drugs in Parkinson's disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation.
Journal: Inflammopharmacology
Published: June 13, 2025
Choice of Insulin Coformulations: Biphasic Insulin Versus Insulin-GlP1RA.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: June 11, 2025
Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies.
Journal: CNS drugs
Published: May 22, 2025
Efficacy and safety of GLP-1 receptor agonists in the treatment of obese patients with chronic heart failure: a meta-analysis.
Journal: Frontiers in cardiovascular medicine
Published: May 22, 2025
An overview of randomized clinical trials of fixed-ratio combinations of basal insulin plus GLP-1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: May 04, 2025
Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonist.
Journal: Diabetes, obesity & metabolism
Published: May 01, 2025
Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?
Journal: Diabetes, obesity & metabolism
Published: April 30, 2025
Last Updated: 10/31/2025